Cardiac changes described in twenty cats with feline infectious peritonitis
Journal of veterinary internal medicine · 2026
RESEARCH HYPOTHESIS — NOT A CLINICAL RECOMMENDATION
In plain language
This study is not about FeLV; it is about feline infectious peritonitis. In twenty cats with FIP, the authors described some cardiac changes, including ventricular wall thickening and increased cTnI. The cats were also tested for FeLV antigen as part of screening, but the provided information does not report those results or any FeLV-specific cardiac findings.
Scientific detail
This prospective clinical study assessed cardiac changes in twenty cats with naturally occurring feline infectious peritonitis and no previous history of heart disease. The source is a 2026 article in the Journal of Veterinary Internal Medicine. Study limitations are not reported in the provided object.
The described findings include left ventricular posterior wall thickening in a subset of cats with FIP, pleural and pericardial effusions in some cats without identification of a cardiac cause for those effusions, and median cTnI at initial evaluation above the reported upper reference interval. In six cats with initially increased cTnI, cTnI normalized after 12 weeks of antiviral treatment. This finding comes from a small retested subset and does not establish a treatment recommendation, optimal antiviral regimen, dose, or causal efficacy, because no control group is described.
The authors conclude that cats with FIP can present with increased cTnI and ventricular wall thickening suggestive of myocarditis or myocardial injury. Based on the provided interpretation, this does not prove a definitive histopathologic diagnosis of myocarditis or a FeLV-related mechanism.
The direct relevance to FeLV is limited. Cats with FIP were tested for feline leukemia virus antigen as part of screening for concurrent infections associated with myocarditis, but the provided source does not report FeLV test results or any FeLV-specific cardiac findings.
What we know
The evidence supports that, in twenty cats with FIP, cardiac changes and biomarkers compatible with possible myocardial injury or myocarditis were described, with evidence level C. FeLV appears only as antigen screening within the study; FeLV results and FeLV-specific cardiac findings are not reported.
What we don't know
From this object, it is not known whether any cat was FeLV-positive, whether FeLV contributed to the cardiac findings, whether the effusions had a specific non-cardiac cause, or whether the observed changes were caused by FIP. The study also does not establish clinical prognosis, definitive histopathologic myocarditis, a treatment recommendation, dose, or causal efficacy of antiviral treatment.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 99/100
Left ventricular posterior wall thickening was observed in a subset of cats with FIP.
Excerpt verified in the source — verbatim, in the source's own language“The left ventricular posterior wall from right parasternal long axis and short axis was thickened in 55% (11/20) and 25% (5/20) of cats, respectively.”
This supports the presence of echocardiographic ventricular wall thickening in some cats with FIP. Because the study is descriptive and no control group is reported, it does not prove causation.
EvidenceLevel C — Preliminary evidenceConfidence 99/100
Pleural and pericardial effusions were observed in some cats, but the study did not identify a cardiac cause for those effusions.
Excerpt verified in the source — verbatim, in the source's own language“Pleural effusion was present in 40% (8/20) of cats and pericardial effusion in 25% (5/20) of cats, but a cardiac cause was not identified for these effusions.”
This supports that effusions were present in the cohort and that the authors did not attribute them to a cardiac cause. It does not establish the non-cardiac cause of the effusions.
EvidenceLevel C — Preliminary evidenceConfidence 98/100
Median cTnI at initial evaluation was above the reported upper reference interval in cats with FIP.
Excerpt verified in the source — verbatim, in the source's own language“Median cTnI at initial evaluation was 0.37 ng/ml (interquartile range [IQR], 0.20-0.83; upper reference interval, 0.20 ng/ml).”
This indicates myocardial injury biomarker elevation at initial evaluation at the group median level. It does not by itself diagnose myocarditis or establish clinical prognosis.
EvidenceLevel C — Preliminary evidenceConfidence 99/100Awaiting human review
In six cats with initially increased cTnI, cTnI normalized after 12 weeks of antiviral treatment.
Excerpt verified in the source — verbatim, in the source's own language“Repeat cTnI was performed after 12 weeks of antiviral treatment in 6 cats that initially had increased cTnI (median initial cTnI, 0.75 ng/mL) and, in all 6 cats, cTnI normalized to < 0.20 ng/mL.”
This reports biomarker normalization in a small retested subset. It does not establish a treatment recommendation, optimal antiviral regimen, dose, or causal efficacy because no control group is described.
EvidenceLevel C — Preliminary evidenceConfidence 98/100
The study prospectively assessed cardiac changes in twenty cats with naturally occurring FIP and no previous history of heart disease.
Excerpt verified in the source — verbatim, in the source's own language“ANIMALS: Twenty cats with naturally occurring FIP without previous history of heart disease.”
This establishes the feline study population described in the source. It does not establish findings in cats with FeLV or in cats with pre-existing heart disease.
EvidenceLevel C — Preliminary evidenceConfidence 98/100
Cats diagnosed with FIP were tested for feline leukemia virus antigen as part of screening for concurrent infections associated with myocarditis.
Excerpt verified in the source — verbatim, in the source's own language“Cats diagnosed with FIP were tested for common concurrent infections associated with myocarditis by testing serum for feline immunodeficiency virus (FIV) antibodies, feline leukemia virus antigen (FeLV), Dirofilaria immitis antigen, Bartonella spp. immunoglobulin G (IgG), and Toxoplasma gondii IgG and immunoglobulin M (IgM) as well as by testing blood for nucleic acids of Bartonella spp. and coronavirus (SARS-COV-2).”
This shows FeLV antigen testing was included in the workup. It does not report FeLV antigen results or show that FeLV contributed to the cardiac findings.
EvidenceLevel C — Preliminary evidenceConfidence 99/100
The authors conclude that cats with FIP can present with increased cTnI and ventricular wall thickening suggestive of myocarditis or myocardial injury.
Excerpt verified in the source — verbatim, in the source's own language“Cats with FIP can present with increases in cTnI and ventricular wall thickening, findings suggestive of myocarditis or myocardial injury.”
This captures the authors' stated conclusion. It suggests possible myocarditis or myocardial injury but does not prove a definitive histopathologic diagnosis or FeLV-related mechanism.
Provenance
Source: Descriptive assessment of cardiac changes in cats with feline infectious peritonitis.
AVA